Marc Stad’s GoodRx Holdings GDRX Stock Holding History

Marc Stad’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,300,000	Closed	-$25.1M	–	43
2022 Q1	$25.1M	Hold	1,300,000	–	–	0.32%	34
2021 Q4	$42.5M	Hold	1,300,000	–	–	0.49%	32
2021 Q3	$53.3M	Hold	1,300,000	–	–	0.7%	28
2021 Q2	$46.8M	Hold	1,300,000	–	–	0.6%	34
2021 Q1	$50.7M	Hold	1,300,000	–	–	0.73%	30
2020 Q4	$52.4M	Hold	1,300,000	–	–	0.78%	23
2020 Q3	$72.3M	Buy	+1,300,000	New	+$68.8M	1.62%	18

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

Marc Stad's GDRX Position: Q2 2022 in Review

Marc Stad sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 1,300,000 shares — an estimated $25.1M sold.

Marc Stad first reported a position in GDRX in Q3 2020 and held it in 7 quarters. The position peaked at $72.3M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Marc Stad reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Marc Stad sold 1,300,000 GoodRx Holdings shares in Q2 2022, an estimated $25.1M.
Marc Stad first reported a position in GoodRx Holdings in Q3 2020 and held it in 7 quarters.
Marc Stad's GoodRx Holdings position peaked at $72.3M in Q3 2020.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Dragoneer Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.